郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2021作者:Nicola L Brice; Hans H Schiffer; Holger Monenschein; Victoria J Mulligan; Keith Page; Justin Powell; Xiao Xu; Toni Cheung; J Russell Burley; Huikai Sun; Louise Dickson; Sean T Murphy; Nidhi Kaushal; Steve Sheardown; Jason Lawrence; Yun Chen; Darian B

药效评价A Solid Supported Membrane-Based Technology for Electrophysical Screening of B0AT1-Modulating Compounds.

期刊:SLAS discovery : advancing life sciences R & D发表年份:2021作者:Carolin Gerbeth-Kreul; Antje Pommereau; Sven Ruf; John L Kane; Theresa Kuntzweiler; Gerhard Hessler; Christian K Engel; Patrick Shum; LinLi Wei; Joerg Czech; Thomas Licher

药效评价Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose.

期刊:Pharmaceutical research发表年份:2021作者:Farrokh Sharifi; Yazan J Meqbil; Andrew Otte; Anna M Gutridge; Arryn T Blaine; Richard M van Rijn; Kinam Park

药效评价A toxicological evaluation of lithium orotate.

期刊:Regulatory toxicology and pharmacology : RTP发表年份:2021作者:Timothy S Murbach; Róbert Glávits; John R Endres; Gábor Hirka; Adél Vértesi; Erzsébet Béres; Ilona Pasics Szakonyiné